Tinzaparin sodium

DRUG7 trials

Sponsors

National Institute of Neurological Disorders and Stroke (NINDS), University of Calgary, University of Vermont, University of Southern California, Assistance Publique - Hôpitaux de Paris

Conditions

CancerIschemic StrokeKidney CancerLung NeoplasmThromboembolismThrombosisVaricose VeinsVenous Thromboembolism

Phase 1

Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery

University of VermontKidney Cancer

Start: 2005-12-31Target: 35Updated: 2013-11-06

Phase 2

Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST)

CompletedNCT00061373

National Institute of Neurological Disorders and Stroke (NINDS)Ischemic Stroke

Start: 2003-05-31End: 2011-07-31Updated: 2013-02-04

Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With Cancer

TerminatedNCT00981903

University of Southern CaliforniaCancer, Venous Thromboembolism

Start: 2005-07-31End: 2015-10-31Updated: 2017-07-06

Phase 3

Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE)

TerminatedNCT03090880

Assistance Publique - Hôpitaux de ParisLung Neoplasm, Venous Thromboembolism

Start: 2018-09-14End: 2021-08-18Updated: 2022-11-17

Phase 4

Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin

CompletedNCT00203658

University of CalgaryThromboembolism, Thrombosis, Venous Thrombosis

Start: 1997-04-30End: 2000-10-31Target: 400Updated: 2007-02-09

Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)

CompletedNCT00203580

University of CalgaryThromboembolism, Thrombosis, Venous Thrombosis

Start: 1994-12-31End: 2002-03-31Target: 910Updated: 2007-02-09

THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)

RecruitingNCT05735639

Imperial College LondonVaricose Veins, Venous Thromboembolism

Start: 2024-01-22End: 2026-12-31Target: 6660Updated: 2025-05-02